Clinical Trial: A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441642) titled 'A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration' on Feb. 24.

Brief Summary: To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Study Start Date: March 30

Study Type: INTERVENTIONAL

Condition: Geographic Atrophy Secondary to Age-related Macular Degeneration

Intervention: DRUG: FWY003

FWY003 arm participants will receive a specific dose of FWY003

DRUG: Placebo

Placebo arm participants will receive placebo

Recrui...